![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Phalanx Labs Private Limited Hyderabad In, based in India, is a pharmaceutical company.
One of their significant offerings is Sildenafil citrate, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2014-283 - Rev 00
This Chemical Type CEP, issued on February 15, 2016, remains in force until February 15, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 2270 associated with this CEP further emphasizes